山(shan)東(dong)(dong)(dong)(dong)金(jin)城(cheng)醫(yi)(yi)藥(yao)(yao)(yao)集團股份有(you)(you)(you)(you)限(xian)公(gong)(gong)(gong)司(si)(簡稱(cheng)“金(jin)城(cheng)醫(yi)(yi)藥(yao)(yao)(yao)”,股票代碼(ma):300233)成立于(yu)2004年,創業(ye)(ye)(ye)板上市企業(ye)(ye)(ye)。目前,公(gong)(gong)(gong)司(si)擁有(you)(you)(you)(you)北京朗依制(zhi)藥(yao)(yao)(yao)有(you)(you)(you)(you)限(xian)公(gong)(gong)(gong)司(si)、上海金(jin)城(cheng)藥(yao)(yao)(yao)業(ye)(ye)(ye)有(you)(you)(you)(you)限(xian)公(gong)(gong)(gong)司(si)、廣東(dong)(dong)(dong)(dong)金(jin)城(cheng)金(jin)素(su)制(zhi)藥(yao)(yao)(yao)有(you)(you)(you)(you)限(xian)公(gong)(gong)(gong)司(si)、山(shan)東(dong)(dong)(dong)(dong)金(jin)城(cheng)生物(wu)藥(yao)(yao)(yao)業(ye)(ye)(ye)有(you)(you)(you)(you)限(xian)公(gong)(gong)(gong)司(si)、山(shan)東(dong)(dong)(dong)(dong)金(jin)城(cheng)醫(yi)(yi)藥(yao)(yao)(yao)化工有(you)(you)(you)(you)限(xian)公(gong)(gong)(gong)司(si)、山(shan)東(dong)(dong)(dong)(dong)金(jin)城(cheng)石墨烯科技(ji)有(you)(you)(you)(you)限(xian)公(gong)(gong)(gong)司(si)、意大利海寶露(lu)有(you)(you)(you)(you)限(xian)責(ze)任公(gong)(gong)(gong)司(si)等18家(jia)參控(kong)股公(gong)(gong)(gong)司(si)。公(gong)(gong)(gong)司(si)通過“實業(ye)(ye)(ye)+資(zi)本”雙輪驅動(dong)發展模(mo)式,已構建形(xing)成獨具金(jin)城(cheng)特(te)色(se)的醫(yi)(yi)藥(yao)(yao)(yao)健康制(zhi)藥(yao)(yao)(yao)工業(ye)(ye)(ye)產(chan)業(ye)(ye)(ye)鏈,業(ye)(ye)(ye)務(wu)范圍涉及生物(wu)制(zhi)藥(yao)(yao)(yao)、頭孢類醫(yi)(yi)藥(yao)(yao)(yao)中間體(ti)、特(te)色(se)原料(liao)藥(yao)(yao)(yao)、終端制(zhi)劑、保健品、新(xin)材料(liao)等產(chan)業(ye)(ye)(ye)領域,并(bing)現已形(xing)成年營業(ye)(ye)(ye)收入超20億元、總(zong)資(zi)產(chan)近50億的產(chan)業(ye)(ye)(ye)規模(mo)。
山東金(jin)城醫(yi)藥(yao)(yao)集團股份有(you)限公(gong)司是(shi)以(yi)三(san)、四代頭(tou)孢(bao)類醫(yi)藥(yao)(yao)中間體、特色原料藥(yao)(yao)、生(sheng)物(wu)制(zhi)藥(yao)(yao)、終(zhong)端制(zhi)劑以(yi)及(ji)(ji)婦(fu)兒產(chan)(chan)品(pin)(pin)(pin)等(deng)為主業的科(ke)研、生(sheng)產(chan)(chan)企業,其中,頭(tou)孢(bao)類醫(yi)藥(yao)(yao)中間體產(chan)(chan)品(pin)(pin)(pin)銷(xiao)量(liang)、銷(xiao)售收入連(lian)續多年位(wei)居(ju)行業前列,是(shi)重要的生(sheng)物(wu)制(zhi)藥(yao)(yao)生(sheng)產(chan)(chan)基(ji)地以(yi)及(ji)(ji)國(guo)內(nei)醫(yi)藥(yao)(yao)健(jian)康(kang)產(chan)(chan)業集團。主導產(chan)(chan)品(pin)(pin)(pin)有(you)谷胱甘肽(tai)(花青(qing)肽(tai)美品(pin)(pin)(pin)牌(pai))、硝呋太(tai)爾膠(jiao)囊(朗依品(pin)(pin)(pin)牌(pai))、富(fu)馬酸比索洛爾膠(jiao)囊(洛雅品(pin)(pin)(pin)牌(pai))、牡蠣碳(tan)酸鈣咀嚼片(pian)(金(jin)娃寧(ning)品(pin)(pin)(pin)牌(pai))、復方木香鋁鎂片(pian)(德瑞夫品(pin)(pin)(pin)牌(pai))等(deng)近(jin)百種(zhong)。
當前,公(gong)司(si)(si)(si)堅持科學發展(zhan),按照(zhao)“大(da)(da)(da)健康、大(da)(da)(da)醫藥(yao)(yao),打造(zao)具有金(jin)城特色(se)制(zhi)藥(yao)(yao)產(chan)業(ye)鏈(lian)(lian)”的產(chan)業(ye)定位和(he)(he)“調整、轉(zhuan)型(xing)、升(sheng)級、發展(zhan)”的戰(zhan)略思(si)路,專(zhuan)注專(zhuan)注金(jin)城特色(se)制(zhi)藥(yao)(yao)產(chan)業(ye)鏈(lian)(lian)三(san)大(da)(da)(da)方向建設(she)——“頭孢類(lei)(lei)抗生素終端制(zhi)劑(ji)產(chan)業(ye)鏈(lian)(lian),多(duo)肽類(lei)(lei)特色(se)生物制(zhi)藥(yao)(yao)產(chan)業(ye)鏈(lian)(lian)和(he)(he)婦科、調節免(mian)疫(yi)制(zhi)劑(ji)特色(se)類(lei)(lei)產(chan)業(ye)鏈(lian)(lian) ”。同時(shi),公(gong)司(si)(si)(si)加快“三(san)個平臺(tai)”建設(she)(技(ji)(ji)術創(chuang)新平臺(tai)、產(chan)業(ye)運營平臺(tai)、組織管控平臺(tai)),加快打造(zao)“四支(zhi)隊(dui)伍(wu)”建設(she)(企業(ye)家隊(dui)伍(wu)、中高層(ceng)管理隊(dui)伍(wu)、專(zhuan)業(ye)人(ren)才隊(dui)伍(wu)、熟練工人(ren)隊(dui)伍(wu)),積極(ji)實踐內(nei)涵(han)式發展(zhan)、外(wai)延式擴張和(he)(he)投(tou)資并購(gou)三(san)種發展(zhan)方式,著力將(jiang)公(gong)司(si)(si)(si)打造(zao)成(cheng)“科技(ji)(ji)化(hua)、生態化(hua)、規范(fan)化(hua)、品牌化(hua)、國際化(hua)”的現代化(hua)醫藥(yao)(yao)健康產(chan)業(ye)集團,助推(tui)醫藥(yao)(yao)進步(bu),創(chuang)享(xiang)健康生活(huo),志在成(cheng)為醫藥(yao)(yao)健康產(chan)業(ye)創(chuang)新型(xing)領軍企業(ye)。